Back to top

Tale of the Tape

ResMed Inc.’s (RMD - Analyst Report) share price has entered into oversold territory with an RSI value of 28.64. The Zacks Consensus Estimate on ResMed Inc.’s earnings for the full year period have moved higher by 1cent over the past two months to $2.26 per share. Currently, ResMed Inc.is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (RMD - Analyst Report) after its recent drop.

Please login to Zacks.com or register to post a comment.